Venus Medtech (Hangzhou) (HKSE:02500) Days Sales Outstanding : 267.92 (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Venus Medtech (Hangzhou) Days Sales Outstanding?

Venus Medtech (Hangzhou)'s average Accounts Receivable for the six months ended in Dec. 2023 was HK$378.6 Mil. Venus Medtech (Hangzhou)'s Revenue for the six months ended in Dec. 2023 was HK$257.9 Mil. Hence, Venus Medtech (Hangzhou)'s Days Sales Outstanding for the six months ended in Dec. 2023 was 267.92.

The historical rank and industry rank for Venus Medtech (Hangzhou)'s Days Sales Outstanding or its related term are showing as below:

HKSE:02500' s Days Sales Outstanding Range Over the Past 10 Years
Min: 157.09 Med: 230.73 Max: 359.1
Current: 248.1

During the past 7 years, Venus Medtech (Hangzhou)'s highest Days Sales Outstanding was 359.10. The lowest was 157.09. And the median was 230.73.

HKSE:02500's Days Sales Outstanding is ranked worse than
94.46% of 812 companies
in the Medical Devices & Instruments industry
Industry Median: 64.77 vs HKSE:02500: 248.10

Venus Medtech (Hangzhou)'s Days Sales Outstanding declined from Dec. 2022 (304.80) to Dec. 2023 (267.92).

Venus Medtech (Hangzhou) Days Sales Outstanding Historical Data

The historical data trend for Venus Medtech (Hangzhou)'s Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Venus Medtech (Hangzhou) Days Sales Outstanding Chart

Venus Medtech (Hangzhou) Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

191.30

253.40

230.73

284.95

222.98

Venus Medtech (Hangzhou) Semi-Annual Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial							330.39	283.28	304.80	253.95	267.92

Competitive Comparison of Venus Medtech (Hangzhou)'s Days Sales Outstanding

For the Medical Devices subindustry, Venus Medtech (Hangzhou)'s Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Venus Medtech (Hangzhou)'s Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Venus Medtech (Hangzhou)'s Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Venus Medtech (Hangzhou)'s Days Sales Outstanding falls into.

Venus Medtech (Hangzhou) Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Venus Medtech (Hangzhou)'s Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (338.798	+	317.86)	/	2 )	/	537.453	*	365
=	328.329					/	537.453	*	365
=	222.98

Venus Medtech (Hangzhou)'s Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (439.286	+	317.86)	/	2 )	/	257.873	*	365 / 2
=	378.573					/	257.873	*	365 / 2
=	267.92

Venus Medtech (Hangzhou) (HKSE:02500) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Venus Medtech (Hangzhou) Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Venus Medtech (Hangzhou)'s Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Venus Medtech (Hangzhou) (HKSE:02500) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Venus Medtech (Hangzhou) Inc (HKSE:02500) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

VMTHF:USA

Address

No. 88, Jiangling Road, Room 311, 3rd Floor, Block 2, Binjiang District, Hangzhou, CHN, 310051

Website

https://www.venusmedtech.com

Venus Medtech (Hangzhou) Inc is engaged in the development and commercialization of transcatheter solutions for structural heart diseases. It has two TAVR products on the market, namely VenusA-Valve, and VenusA-Plus. VenusA-Valve is its first-generation TAVR device, which is used to treat severe Aortic Stenosis (AS) using a transcatheter approach. VenusA-Plus is an upgraded product of VenusA-Valve. Geographically all of the revenue is derived from Mainland China.

Venus Medtech (Hangzhou) (HKSE:02500) Headlines

No Headlines